Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1975 2
1982 1
1984 1
1985 2
1986 6
1987 6
1988 5
1989 13
1990 7
1992 17
1993 9
1994 19
1995 12
1996 16
1997 19
1998 28
1999 33
2000 30
2001 23
2002 22
2003 32
2004 25
2005 39
2006 50
2007 50
2008 37
2009 31
2010 47
2011 51
2012 43
2013 46
2014 39
2015 49
2016 47
2017 51
2018 40
2019 41
2020 28
2021 41
2022 41
2023 33
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

1,039 results

Results by year

Filters applied: . Clear all
Page 1
Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study.
Tokunaga T, Sakashita M, Haruna T, Asaka D, Takeno S, Ikeda H, Nakayama T, Seki N, Ito S, Murata J, Sakuma Y, Yoshida N, Terada T, Morikura I, Sakaida H, Kondo K, Teraguchi K, Okano M, Otori N, Yoshikawa M, Hirakawa K, Haruna S, Himi T, Ikeda K, Ishitoya J, Iino Y, Kawata R, Kawauchi H, Kobayashi M, Yamasoba T, Miwa T, Urashima M, Tamari M, Noguchi E, Ninomiya T, Imoto Y, Morikawa T, Tomita K, Takabayashi T, Fujieda S. Tokunaga T, et al. Among authors: seki n. Allergy. 2015 Aug;70(8):995-1003. doi: 10.1111/all.12644. Epub 2015 May 26. Allergy. 2015. PMID: 25945591 Free PMC article.
[Eosinophilic chronic rhinosinusitis].
Fujieda S, Sakashita M, Tokunaga T, Okano M, Haruna T, Yoshikawa M, Ohtori N, Asaka D, Haruna S, Nakayama T, Ishitoya J, Sakuma Y, Hirakawa K, Takeno S, Himi T, Seki N, Iino Y, Yoshida N, Kobayashi M, Sakaida H, Kondo K, Yamasoba T, Miwa T, Yamada K, Kawata R, Terada T, Kawauchi H, Morikura I, Ikeda K, Murata J, Ikeda H, Noguchi E, Tamari M, Hirota T, Imoto Y, Takabayashi T, Tomita K, Ninomiya T, Morikawa T, Urashima M. Fujieda S, et al. Among authors: seki n. Arerugi. 2015 Feb;64(1):38-45. Arerugi. 2015. PMID: 25779061 Review. Japanese. No abstract available.
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).
Yamazaki K, Nagase M, Tamagawa H, Ueda S, Tamura T, Murata K, Eguchi Nakajima T, Baba E, Tsuda M, Moriwaki T, Esaki T, Tsuji Y, Muro K, Taira K, Denda T, Funai S, Shinozaki K, Yamashita H, Sugimoto N, Okuno T, Nishina T, Umeki M, Kurimoto T, Takayama T, Tsuji A, Yoshida M, Hosokawa A, Shibata Y, Suyama K, Okabe M, Suzuki K, Seki N, Kawakami K, Sato M, Fujikawa K, Hirashima T, Shimura T, Taku K, Otsuji T, Tamura F, Shinozaki E, Nakashima K, Hara H, Tsushima T, Ando M, Morita S, Boku N, Hyodo I. Yamazaki K, et al. Among authors: seki n. Ann Oncol. 2016 Aug;27(8):1539-46. doi: 10.1093/annonc/mdw206. Epub 2016 May 13. Ann Oncol. 2016. PMID: 27177863 Free article. Clinical Trial.
Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer.
Qiu B, Cai K, Chen C, Chen J, Chen KN, Chen QX, Cheng C, Dai TY, Fan J, Fan Z, Hu J, Hu WD, Huang YC, Jiang GN, Jiang J, Jiang T, Jiao WJ, Li HC, Li Q, Liao YD, Liu HX, Liu JF, Liu L, Liu Y, Long H, Luo QQ, Ma HT, Mao NQ, Pan XJ, Tan F, Tan LJ, Tian H, Wang D, Wang WX, Wei L, Wu N, Wu QC, Xiang J, Xu SD, Yang L, Zhang H, Zhang L, Zhang P, Zhang Y, Zhang Z, Zhu K, Zhu Y, Um SW, Oh IJ, Tomita Y, Watanabe S, Nakada T, Seki N, Hida T, Sasada S, Uchino J, Sugimura H, Dermime S, Cappuzzo F, Rizzo S, Cho WC, Crucitti P, Longo F, Lee KY, De Ruysscher D, Vanneste BGL, Furqan M, Sieren JC, Yendamuri S, Merrell KW, Molina JR, Metro G, Califano R, Bongiolatti S, Provencio M, Hofman P, Gao S, He J. Qiu B, et al. Among authors: seki n. Transl Lung Cancer Res. 2021 Sep;10(9):3713-3736. doi: 10.21037/tlcr-21-634. Transl Lung Cancer Res. 2021. PMID: 34733623 Free PMC article. Review. No abstract available.
English education for healthcare professionals in Japan.
Moross J, Seki N, Morio I. Moross J, et al. Among authors: seki n. Jpn Dent Sci Rev. 2017 Nov;53(4):111-116. doi: 10.1016/j.jdsr.2017.01.001. Epub 2017 Mar 3. Jpn Dent Sci Rev. 2017. PMID: 29201255 Free PMC article. Review.
Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Homma T, Nagata N, Hashimoto M, Iwata-Yoshikawa N, Seki NM, Shiwa-Sudo N, Ainai A, Dohi K, Nikaido E, Mukai A, Ukai Y, Nakagawa T, Shimo Y, Maeda H, Shirai S, Aoki M, Sonoyama T, Sato M, Fumoto M, Nagira M, Nakata F, Hashiguchi T, Suzuki T, Omoto S, Hasegawa H. Homma T, et al. Among authors: seki nm. Sci Rep. 2022 Dec 2;12(1):20861. doi: 10.1038/s41598-022-25418-5. Sci Rep. 2022. PMID: 36460696 Free PMC article.
Amino acid catabolite markers for early prognostication of pneumonia in patients with COVID-19.
Maeda R, Seki N, Uwamino Y, Wakui M, Nakagama Y, Kido Y, Sasai M, Taira S, Toriu N, Yamamoto M, Matsuura Y, Uchiyama J, Yamaguchi G, Hirakawa M, Kim YG, Mishima M, Yanagita M, Suematsu M, Sugiura Y. Maeda R, et al. Among authors: seki n. Nat Commun. 2023 Dec 20;14(1):8469. doi: 10.1038/s41467-023-44266-z. Nat Commun. 2023. PMID: 38123556 Free PMC article.
Gut Microbiota Prevents Sugar Alcohol-Induced Diarrhea.
Hattori K, Akiyama M, Seki N, Yakabe K, Hase K, Kim YG. Hattori K, et al. Among authors: seki n. Nutrients. 2021 Jun 12;13(6):2029. doi: 10.3390/nu13062029. Nutrients. 2021. PMID: 34204751 Free PMC article.
1,039 results